These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 27237833)

  • 1. Review: LC coupled to low- and high-resolution mass spectrometry for new psychoactive substance screening in biological matrices - Where do we stand today?
    Meyer MR; Maurer HH
    Anal Chim Acta; 2016 Jul; 927():13-20. PubMed ID: 27237833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology.
    Wu AH; Gerona R; Armenian P; French D; Petrie M; Lynch KL
    Clin Toxicol (Phila); 2012 Sep; 50(8):733-42. PubMed ID: 22888997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic forensic toxicological analysis by liquid-chromatography-quadrupole-time-of-flight mass spectrometry in serum and comparison to gas chromatography-mass spectrometry.
    Grapp M; Kaufmann C; Streit F; Binder L
    Forensic Sci Int; 2018 Jun; 287():63-73. PubMed ID: 29649771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances of liquid chromatography-(tandem) mass spectrometry in clinical and forensic toxicology - An update.
    Remane D; Wissenbach DK; Peters FT
    Clin Biochem; 2016 Sep; 49(13-14):1051-71. PubMed ID: 27452180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-resolution mass spectrometry in toxicology: current status and future perspectives.
    Maurer HH; Meyer MR
    Arch Toxicol; 2016 Sep; 90(9):2161-2172. PubMed ID: 27369376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives of liquid chromatography coupled to low- and high-resolution mass spectrometry for screening, identification, and quantification of drugs in clinical and forensic toxicology.
    Maurer HH
    Ther Drug Monit; 2010 Jun; 32(3):324-7. PubMed ID: 20418802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broad Screening and Identification of Novel Psychoactive Substances in Plasma by High-Performance Liquid Chromatography-High-Resolution Mass Spectrometry and Post-run Library Matching.
    Montesano C; Vannutelli G; Gregori A; Ripani L; Compagnone D; Curini R; Sergi M
    J Anal Toxicol; 2016 Sep; 40(7):519-28. PubMed ID: 27466313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent developments in urinalysis of metabolites of new psychoactive substances using LC-MS.
    Peters FT
    Bioanalysis; 2014 Aug; 6(15):2083-107. PubMed ID: 25322784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening of Novel Psychoactive Substances in Postmortem Matrices by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS-MS).
    Fagiola M; Hahn T; Avella J
    J Anal Toxicol; 2018 Oct; 42(8):562-569. PubMed ID: 30371846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current applications of high-resolution mass spectrometry for the analysis of new psychoactive substances: a critical review.
    Pasin D; Cawley A; Bidny S; Fu S
    Anal Bioanal Chem; 2017 Oct; 409(25):5821-5836. PubMed ID: 28634759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MASS SPECTROMETRY ANALYSIS OF DRUGS OF ABUSE: CHALLENGES AND EMERGING STRATEGIES.
    Borden SA; Palaty J; Termopoli V; Famiglini G; Cappiello A; Gill CG; Palma P
    Mass Spectrom Rev; 2020 Sep; 39(5-6):703-744. PubMed ID: 32048319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simple and rapid screening procedure for 143 new psychoactive substances by liquid chromatography-tandem mass spectrometry.
    Adamowicz P; Tokarczyk B
    Drug Test Anal; 2016 Jul; 8(7):652-67. PubMed ID: 25976069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in analysis of new psychoactive substances by means of liquid chromatography coupled with low-resolution tandem mass spectrometry.
    Feigel B; Adamowicz P; Wybraniec S
    Anal Bioanal Chem; 2024 Jan; 416(1):107-124. PubMed ID: 38001373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the future of (ultra) high performance liquid chromatography coupled to low and high resolution mass spectrometry for toxicological drug screening?
    Maurer HH
    J Chromatogr A; 2013 May; 1292():19-24. PubMed ID: 22964051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Resolution Mass Spectrometry for Untargeted Drug Screening.
    Wu AH; Colby J
    Methods Mol Biol; 2016; 1383():153-66. PubMed ID: 26660184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic cathinone pharmacokinetics, analytical methods, and toxicological findings from human performance and postmortem cases.
    Ellefsen KN; Concheiro M; Huestis MA
    Drug Metab Rev; 2016 May; 48(2):237-65. PubMed ID: 27249313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications of liquid chromatography--mass spectrometry in analytical toxicology: a review.
    Hoja H; Marquet P; Verneuil B; Lotfi H; Pénicaut B; Lachâtre G
    J Anal Toxicol; 1997; 21(2):116-26. PubMed ID: 9083829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New psychoactive substances as part of polydrug abuse within opioid maintenance treatment revealed by comprehensive high-resolution mass spectrometric urine drug screening.
    Heikman P; Sundström M; Pelander A; Ojanperä I
    Hum Psychopharmacol; 2016 Jan; 31(1):44-52. PubMed ID: 26763789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspects of matrix effects in applications of liquid chromatography-mass spectrometry to forensic and clinical toxicology--a review.
    Peters FT; Remane D
    Anal Bioanal Chem; 2012 Jun; 403(8):2155-72. PubMed ID: 22549818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing the linear dynamic range in LC-MS: is it valid to use a less abundant isotopologue?
    Trobbiani S; Stockham P; Scott T
    Drug Test Anal; 2017 Oct; 9(10):1630-1636. PubMed ID: 28207195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.